An editorial in the Los Angeles Times examines a push by states across the country proposing regulations to govern prescription drug data mining. Looking at market research companies that pay pharmacists for details contained in prescriptions, "including the name of the doctor and the patient, the drug prescribed and the dosage," the report notes that companies then compile the information into databases. "Drug makers should be able to market their products, but their First Amendment rights shouldn't guarantee them access to sensitive data that wouldn't exist but for the government's requirement that doctors and patients disclose it," the editorial states. 
Full Story


If you want to comment on this post, you need to login.